Beauty Health (NASDAQ:SKIN) Stock Price Expected to Rise, TD Cowen Analyst Says

Key Points

• TD Cowen raised its price target for Beauty Health (NASDAQ:SKIN) from $2.00 to $2.50, suggesting a potential upside of 7.53% from the current stock price.
• Multiple analysts have differing ratings on the stock, with Roth Capital giving it a "buy" rating at a price target of $3.50 and Stifel Nicolaus raising its target to $4.00, while the average rating remains a "hold" with a price target of $2.81.
• Beauty Health reported quarterly earnings surpassing expectations, with $0.03 earnings per share and $78.20 million in revenue, indicating a strong operational performance.

Beauty Health (NASDAQ:SKIN - Get Free Report) had its price objective raised by stock analysts at TD Cowen from $2.00 to $2.50 in a report released on Monday,Benzinga reports. The brokerage presently has a "hold" rating on the stock. TD Cowen's target price indicates a potential upside of 7.53% from the stock's current price.

Other equities analysts also recently issued reports about the company. Roth Capital initiated coverage on Beauty Health in a research report on Friday. They set a "buy" rating and a $3.50 price objective on the stock. Stifel Nicolaus boosted their target price on Beauty Health from $3.00 to $4.00 and gave the company a "hold" rating in a research report on Friday, August 1st. Finally, Wall Street Zen raised Beauty Health from a "hold" rating to a "buy" rating in a research report on Saturday, August 9th. One research analyst has rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $2.81.

Beauty Health Trading Up 2.0%

Shares of SKIN stock traded up $0.05 during trading hours on Monday, hitting $2.33. 155,100 shares of the company were exchanged, compared to its average volume of 881,715. The company has a 50 day simple moving average of $2.01 and a two-hundred day simple moving average of $1.65. Beauty Health has a fifty-two week low of $0.78 and a fifty-two week high of $2.69. The company has a debt-to-equity ratio of 4.91, a quick ratio of 4.15 and a current ratio of 5.15. The firm has a market cap of $294.86 million, a P/E ratio of -8.30 and a beta of 1.22.

Beauty Health (NASDAQ:SKIN - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.03 earnings per share for the quarter, topping analysts' consensus estimates of ($0.06) by $0.09. Beauty Health had a negative net margin of 6.13% and a negative return on equity of 32.82%. The company had revenue of $78.20 million for the quarter, compared to the consensus estimate of $74.67 million. Beauty Health has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities analysts anticipate that Beauty Health will post -0.25 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of SKIN. Northern Trust Corp increased its stake in Beauty Health by 6.8% in the fourth quarter. Northern Trust Corp now owns 663,752 shares of the company's stock valued at $1,055,000 after purchasing an additional 42,078 shares in the last quarter. BNP Paribas Financial Markets purchased a new stake in shares of Beauty Health in the 4th quarter valued at $129,000. Millennium Management LLC lifted its position in shares of Beauty Health by 30.6% in the 4th quarter. Millennium Management LLC now owns 3,118,970 shares of the company's stock worth $4,959,000 after purchasing an additional 730,647 shares during the period. ProShare Advisors LLC increased its stake in Beauty Health by 49.0% during the 4th quarter. ProShare Advisors LLC now owns 20,959 shares of the company's stock valued at $33,000 after purchasing an additional 6,896 shares in the last quarter. Finally, Prescott Group Capital Management L.L.C. grew its position in Beauty Health by 47.0% during the first quarter. Prescott Group Capital Management L.L.C. now owns 646,798 shares of the company's stock valued at $867,000 after buying an additional 206,798 shares during the period. 93.26% of the stock is owned by institutional investors.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.